Passage BIO, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9281e9aa-83df-4005-a67b-e1f816ba7529/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-49.3M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-022549 |
| FY 2024 | $-70.4M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-002101 |
| FY 2023 | $-108.4M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002310 |
| FY 2022 | $-138.4M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-002833 |
| FY 2021 | $-185.7M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002719 |
| FY 2020 | $-112.9M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002287 |
| FY 2019 | $-37.2M | 2019-01-01 – 2019-12-31 | evidence 0001558370-21-002287 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).